Use Of GW274150 In The Prophylactic Treatment Of Migraine

NCT00242866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: GW274150
OTHER: Placebo

Sponsor

GlaxoSmithKline